2007
DOI: 10.1136/vr.160.17.578
|View full text |Cite
|
Sign up to set email alerts
|

Use of a transdermal matrix patch of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data

Abstract: Six domestic shorthair cats, aged three to four years and weighing 5.1 to 7.4 kg, were used to assess the thermal antinociceptive effect of a transdermal buprenorphine patch, designed to supply 35 mug buprenorphine/hour, which was applied to the shaved thorax. The cats' thermal thresholds were tested before the patch was applied and two, four, six, eight, 10, 12, 14 and 16 hours after it had been applied, and then every six hours until it was removed after 72 hours, and for a further 24 hours afterwards. Blood… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
76
6

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 50 publications
(86 citation statements)
references
References 34 publications
4
76
6
Order By: Relevance
“…, 2003b, 2005b). In the present study, thermal threshold increased by only 3 °C after subcutaneous administration and it did not increase at all when a 35 μ g/h buprenorphine patch was used (Murrell et al. , 2006).…”
Section: Discussionmentioning
confidence: 51%
See 1 more Smart Citation
“…, 2003b, 2005b). In the present study, thermal threshold increased by only 3 °C after subcutaneous administration and it did not increase at all when a 35 μ g/h buprenorphine patch was used (Murrell et al. , 2006).…”
Section: Discussionmentioning
confidence: 51%
“…, 2002; Robertson et al. , 2003a,b; Lascelles & Robertson, 2004a,b; Murrell et al. , 2006; Wegner et al ., 2004; Robertson et al.…”
Section: Introductionmentioning
confidence: 99%
“…2003; Lascelles & Robertson 2004a,b; Wegner et al. 2004; Murrell et al. 2007), but additional stimuli are needed for comprehensive coverage which can be related more closely to clinical pain.…”
Section: Discussionmentioning
confidence: 99%
“…Buprenorphine, a partial mu (MOP) agonist has been previously studied in cats using the thermal device (Robertson et al. 2003a,b, 2005a,b; Murrell et al. 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Transdermal patches (fentanyl, lidocaine and buprenorphine) are adhesive patches that are placed on the skin to deliver a specific dose of drug through the skin and into the plasma. The patch provides a controlled release of the drug through a porous membrane with a drug reservoir . In cats, the analgesic effects of fentanyl patches can be highly variable due to the individual variability in its pharmacokinetics.…”
Section: Section 2: Pain Managementmentioning
confidence: 99%